01 Jan Carrageenan-based gel retains limited anti-HIV-1 activity 8-24 hours after vaginal application by HIV-infected Thai women enrolled in a phase I safety trial
Posted at 00:00h
in
Authored by: Haaland Richard E., Chaowanachan Thanyanan, Evans-Strickfaden Tammy, van de Wijgert Janneke H., Kilmarx Peter H., McLean Catherine A., Hart Clyde E.
In: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 61(5), 2012, p.e71-e73
http://www.ncbi.nlm.nih.gov/pubmed/23183152